{"id":70789,"date":"2026-05-12T11:08:40","date_gmt":"2026-05-12T11:08:40","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70789"},"modified":"2026-05-21T07:14:09","modified_gmt":"2026-05-21T07:14:09","slug":"ahk-cu","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nl\/ahk-cu\/","title":{"rendered":"AHK-Cu"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Quick Answer \u2014 What is AHK-Cu?<\/h3>\n<p style=\"margin: 0;\"><strong>AHK-Cu<\/strong> (Alanyl-Histidyl-Lysine Copper(II) complex) is a synthetic copper-binding tripeptide and the sister molecule to <a href=\"https:\/\/medsbase.com\/nl\/ghk-cu\/\">GHK-Cu<\/a>. While GHK-Cu is the canonical skin and wound-healing copper peptide, AHK-Cu&#8217;s research signal is concentrated in <strong>hair follicle biology<\/strong> \u2014 published preclinical work documents stimulation of dermal papilla cells, follicular enlargement, increased follicular vascularization, and prolongation of the anagen growth phase. Supplied in 20\u00a0mg and 50\u00a0mg lyophilized vials for laboratory research use only.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Wat u krijgt bij MedsBase:<\/strong> Onderzoekskwaliteit lyofiliseerde peptiden \u00b7 HPLC \u226599% zuiverheid (COA op aanvraag) \u00b7 Discrete temperatuurstabiele verpakking \u00b7 Wereldwijde peptidekoerier \u00b7 1.400+ geverifieerd <a href=\"https:\/\/medsbase.com\/nl\/reviews\/\">klantbeoordelingen<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Elke bestelling is gedekt door onze <a href=\"https:\/\/medsbase.com\/nl\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specificatie<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS-nummer<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">110374-12-4 (AHK-Cu); 71567-06-1 (AHK free peptide)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molecuulformule<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>15<\/sub>H<sub>25<\/sub>CuN<sub>6<\/sub>O<sub>4<\/sub> (1:1 copper complex)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Moleculair gewicht<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~417 Da (copper complex)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequentie<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Ala-His-Lys (AHK, 3 amino acids) coordinated to a single Cu<sup>2+<\/sup> ion via the imidazole nitrogen of His, the amino terminus of Ala, and the deprotonated peptide nitrogen between Ala and His<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Form<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilized copper-peptide complex (blue to blue-violet powder; colour comes from the d-d transitions of bound Cu<sup>2+<\/sup>)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Zuiverheid<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC geverifieerd, COA op aanvraag)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Opslag<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofiliseerd: 2\u20138 \u00b0C (koelkast) voor werkvoorraad; \u221220 \u00b0C voor langdurige opslag van ongeopende flesjes. Gereconstitueerd: 2\u20138 \u00b0C, gebruik binnen ~30 dagen. Bescherm tegen licht. Vries de gereconstitueerde oplossing niet in en ontdooi deze niet.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Oplosbaarheid<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bacteriostatic water (recommended) or sterile water for shorter use windows. Soluble in water; the dissolved solution retains the characteristic blue colour of the bound Cu<sup>2+<\/sup>.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Onderzoeksgebruik<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Alleen voor laboratoriumonderzoek. Niet voor humaan of veterinair diagnostisch of therapeutisch gebruik.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>What Is AHK-Cu?<\/h2>\n<p><strong>AHK-Cu<\/strong> (Alanyl-Histidyl-Lysine Copper(II) complex) is a synthetic copper-binding tripeptide composed of the three amino acids Ala, His, and Lys, coordinated to a single Cu<sup>2+<\/sup> ion. It is the sister molecule of the more extensively studied <a href=\"https:\/\/medsbase.com\/nl\/ghk-cu\/\">GHK-Cu<\/a> \u2014 both belong to the &#8220;copper peptide&#8221; class, both share the same Cu-coordination architecture using a histidine residue, and both are studied in dermatological research contexts. Where they diverge is in primary research signal: GHK-Cu is the canonical research peptide for skin remodelling, wound healing, and connective-tissue repair, while AHK-Cu&#8217;s most-cited research applications are in <strong>hair follicle biology<\/strong>.<\/p>\n<p>The well-characterised molecular composition is C<sub>15<\/sub>H<sub>25<\/sub>CuN<sub>6<\/sub>O<sub>4<\/sub>, molecular weight approximately 417\u00a0Da. The Cu<sup>2+<\/sup> ion coordinates with the tripeptide via the imidazole nitrogen of histidine, the amino terminus of alanine, and the deprotonated peptide nitrogen between Ala and His \u2014 the same square-planar coordination geometry as in GHK-Cu. The bound copper gives both compounds their characteristic blue-to-violet colour in solid and dissolved form \u2014 researchers reconstituting AHK-Cu should expect a visibly blue working solution.<\/p>\n<p>AHK-Cu is supplied as a high-purity lyophilized copper-peptide complex for reconstitution with bacteriostatic water. The compound is <strong>niet goedgekeurd<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. The research-grade AHK-Cu sold here is supplied <strong>uitsluitend voor laboratoriumonderzoek<\/strong> and is not intended for human or veterinary administration. For the sister skin-research copper peptide, see our <a href=\"https:\/\/medsbase.com\/nl\/ghk-cu\/\">GHK-Cu<\/a> product page.<\/p>\n<h2>Mechanism of Action \u2014 Copper Delivery to Hair Follicle Papilla Cells<\/h2>\n<p>What makes AHK-Cu mechanistically distinctive among copper peptides is its <strong>preferential signalling at dermal papilla cells<\/strong> in the hair follicle \u2014 the mesenchymal cells at the base of each follicle that regulate hair-shaft production and cycle through the growth (anagen), regression (catagen), and rest (telogen) phases. Published research has documented three principal mechanisms:<\/p>\n<ul>\n<li><strong>Copper delivery to dermal papilla cells<\/strong> \u2014 The Cu<sup>2+<\/sup> ion is the active payload of AHK-Cu (and of GHK-Cu in skin research). The tripeptide is a vehicle that ferries the metal ion into target tissue, where copper participates in multiple enzyme cofactor roles including lysyl oxidase (collagen and elastin cross-linking) and superoxide dismutase (oxidative-stress buffering). At the hair follicle, dermal papilla cells take up copper from AHK-Cu and use it to support the follicular extracellular matrix and oxidative-stress management that anagen requires.<\/li>\n<li><strong>VEGF upregulation and follicular vascularization<\/strong> \u2014 AHK-Cu stimulates vascular endothelial growth factor (VEGF) expression in dermal papilla cells. The downstream effect is increased follicular perfusion \u2014 new capillary growth at the follicle base that supports the metabolic demands of the rapidly-proliferating hair-matrix keratinocytes during anagen. This perfusion-enhancement mechanism overlaps with the minoxidil mechanism but operates via a fundamentally different pathway (direct copper-peptide signalling rather than ATP-sensitive potassium channel modulation).<\/li>\n<li><strong>Anagen phase prolongation and follicular enlargement<\/strong> \u2014 In published rodent hair-cycle research, AHK-Cu administration prolongs the duration of the anagen growth phase and increases overall follicular size. The combined effect is more hair-shaft production per follicle per cycle. The mechanism appears to be downstream of the copper-delivery and VEGF-upregulation steps \u2014 healthy, well-perfused follicles in a copper-replete environment sustain anagen for longer before transitioning to catagen.<\/li>\n<\/ul>\n<p>The mechanism is fundamentally different from the two FDA-approved hair-loss compounds: finasteride blocks 5-alpha-reductase to lower scalp DHT (hormonal mechanism); minoxidil opens ATP-sensitive potassium channels to vasodilate follicular vessels (vascular mechanism). AHK-Cu provides direct mesenchymal-cell signalling and copper-cofactor delivery, working at a different point in follicular biology than either FDA-approved compound \u2014 which makes it a useful research tool for dissecting follicular cell biology independent of androgen-axis or vasodilation-mediated mechanisms. Subcutaneous, topical, and intrafollicular injection routes are all documented in published research.<\/p>\n<h2>Gepubliceerde onderzoeksapplicaties<\/h2>\n<p>AHK-Cu is used in laboratory research contexts that investigate:<\/p>\n<ul>\n<li><strong>Hair follicle biology research<\/strong> \u2014 dermal papilla cell proliferation assays, follicular size measurement, hair-shaft diameter analysis, organ-cultured hair follicle research; canonical copper-peptide research compound for the hair-axis (Pyo et al., J Korean Med Sci 2007; Uno &amp; Kurata, J Investig Dermatol)<\/li>\n<li><strong>Hair cycle research<\/strong> \u2014 anagen \/ catagen \/ telogen phase duration, anagen induction in telogen follicles, comparative dose-response with established hair-axis comparator compounds<\/li>\n<li><strong>Follicular vascularization research<\/strong> \u2014 VEGF expression, capillary density at the follicle base, peri-follicular perfusion measurement<\/li>\n<li><strong>Comparative copper peptide research<\/strong> \u2014 head-to-head with <a href=\"https:\/\/medsbase.com\/nl\/ghk-cu\/\">GHK-Cu<\/a> for dermatological research; AHK-Cu favoured for hair-axis endpoints, GHK-Cu favoured for skin\/wound\/anti-aging endpoints<\/li>\n<li><strong>Topical and intradermal formulation research<\/strong> \u2014 AHK-Cu is one of the more-studied copper peptides for topical and intradermal delivery; published research investigates skin-penetration depth, follicular targeting via different vehicle formulations<\/li>\n<li><strong>Hair-loss mechanism dissection<\/strong> \u2014 alongside finasteride (androgen-axis) and minoxidil (vascular axis), AHK-Cu provides a third orthogonal research mechanism (mesenchymal-cell + copper-cofactor + VEGF axis); useful for mechanism-of-action research designs<\/li>\n<li><strong>Collagen and elastin research<\/strong> \u2014 copper&#8217;s role as cofactor for lysyl oxidase makes copper peptides relevant to research on extracellular matrix crosslinking; AHK-Cu shares this mechanism with GHK-Cu at the broader level although hair-axis effects predominate.<\/li>\n<\/ul>\n<p>For broader context on where AHK-Cu fits within the copper-peptide and dermatological research landscape, see <a href=\"https:\/\/medsbase.com\/nl\/ghk-cu\/\">GHK-Cu<\/a> as the canonical skin-research copper peptide, <a href=\"https:\/\/medsbase.com\/nl\/bpc-157\/\">BPC-157<\/a> for tissue-repair research, and <a href=\"https:\/\/medsbase.com\/nl\/tb-500\/\">TB-500<\/a> for systemic recovery research. Browse the full <a href=\"https:\/\/medsbase.com\/nl\/peptides\/\">onderzoekspeptiden catalogus<\/a> voor gerelateerde verbindingen.<\/p>\n<h2>Beschikbare sterktes en concentraties<\/h2>\n<p>MedsBase stocks AHK-Cu in two lyophilized vial sizes calibrated to typical research protocol lengths. Each strength is available in 10-vial or 20-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Vulsterkte<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typisch Onderzoeksgebruik<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Verpakkingsgroottes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>20 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard research strength \u2014 topical formulation and short-cycle protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 of 20 flesjes<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>50 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Bulk research vial, extended cycles, lowest per-mg cost, multi-cohort follicle research<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 of 20 flesjes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized copper-peptide complex, 99%+ HPLC purity). Higher-mg vials are particularly useful for AHK-Cu because of the relatively large doses typical in topical-formulation research compared with the microgram-range systemic peptides. Higher-mg vials require smaller reconstitution volumes per unit dose.<\/p>\n<h2>How It Compares \u2014 AHK-Cu vs GHK-Cu<\/h2>\n<p>AHK-Cu and <a href=\"https:\/\/medsbase.com\/nl\/ghk-cu\/\">GHK-Cu<\/a> are sister copper-binding tripeptides that share the same Cu-coordination chemistry but differ in the first amino-acid residue (Ala vs Gly). This minor structural difference produces qualitatively different research signals: GHK-Cu dominates skin\/wound\/anti-aging research while AHK-Cu&#8217;s strongest signal is in hair follicle biology.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">AHK-Cu<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">GHK-Cu<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Lengte<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 amino acids (tripeptide)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 amino acids (tripeptide)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Sequentie<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ala-His-Lys<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Gly-His-Lys<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Copper coordination<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1:1 Cu<sup>2+<\/sup> via His + N-terminus<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1:1 Cu<sup>2+<\/sup> via His + N-terminus<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primair onderzoekssignaal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Hair follicle biology, anagen prolongation<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Skin remodelling, wound healing, anti-aging<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Target cell type<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dermal papilla cells (hair follicle)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dermal fibroblasts, keratinocytes (skin)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>VEGF signalling<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Strong \u2014 follicular vascularization<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Moderate \u2014 wound-bed angiogenesis<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Endogenous occurrence<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Synthetic (no significant endogenous pool)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Endogenous (declines with age in plasma)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typische onderzoeksdosis<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u201310\u00a0mg topical \/ 1\u20135\u00a0mg subcutaneous<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u20135\u00a0mg topical \/ 0.5\u20132\u00a0mg subcutaneous<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For hair-axis research, AHK-Cu is the canonical first choice because of the dermal-papilla-cell selectivity and the documented anagen-prolongation signal. For skin remodelling, wound healing, and anti-aging research, <a href=\"https:\/\/medsbase.com\/nl\/ghk-cu\/\">GHK-Cu<\/a> is the canonical reference. Some research designs use both in parallel arms to dissect copper-peptide effects that are shared (general Cu cofactor delivery) from effects that are sequence-specific (cell-type selectivity).<\/p>\n<h2>Opslag en Reconstituering<\/h2>\n<p><strong>Voor reconstituering:<\/strong> store lyophilized vials refrigerated at 2\u20138\u00a0\u00b0C in original packaging for short-term working stock. For unopened long-term storage, freeze at \u221220\u00a0\u00b0C. Lyophilized AHK-Cu is stable under refrigeration for up to 24 months and at \u221220\u00a0\u00b0C for up to 36 months. Avoid freeze-thaw cycles on the lyophilized powder. The Cu<sup>2+<\/sup> coordination is stable in the lyophilized form; once reconstituted, prolonged exposure to light or reducing agents can affect the copper oxidation state.<\/p>\n<p><strong>Reconstitueringsprocedure:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 20\u00a0mg vial, 2.0\u00a0mL of bacteriostatic water yields a 10\u00a0mg\/mL working concentration \u2014 0.1\u00a0mL delivers 1\u00a0mg; 0.5\u00a0mL delivers 5\u00a0mg. Swirl gently \u2014 do <strong>niet<\/strong> shake \u2014 and allow 2\u20135 minutes for full dissolution. A correctly reconstituted solution should be clear with the characteristic blue colour of the bound Cu<sup>2+<\/sup>. Cloudiness or precipitate indicates a problem with reconstitution; discard and try again.<\/p>\n<p><strong>Na reconstitutie:<\/strong> store refrigerated at 2\u20138\u00a0\u00b0C and use within 30 days for optimal stability. Do not freeze the reconstituted solution \u2014 freeze-thaw cycles degrade peptide integrity. Protect from direct light at all times. For topical formulation research, AHK-Cu can be incorporated into a wide range of vehicles (creams, gels, serums) for follicle-research delivery; published vehicle research includes liposomal and microemulsion formulations for enhanced follicular penetration.<\/p>\n<h2 id=\"faqs\">Veelgestelde vragen<\/h2>\n<h3>What is AHK-Cu used for in research?<\/h3>\n<p>AHK-Cu is used in laboratory research investigating hair follicle biology, dermal papilla cell proliferation, anagen phase prolongation, follicular vascularization, hair-shaft diameter, comparative copper-peptide pharmacology, topical and intradermal formulation research, and mechanism-of-action dissection of hair-loss biology distinct from the androgen-axis (finasteride) and vascular (minoxidil) mechanisms. It is the canonical copper-peptide research compound for the hair-axis. The research-grade AHK-Cu sold here is <strong>niet<\/strong> FDA-goedgekeurd en wordt strikt geleverd voor laboratoriumonderzoek alleen.<\/p>\n<h3>How is AHK-Cu different from GHK-Cu?<\/h3>\n<p>Both are copper-binding tripeptides that share the same Cu-coordination architecture (His-mediated 1:1 Cu<sup>2+<\/sup> binding). They differ in the first amino-acid residue \u2014 alanine in AHK-Cu, glycine in GHK-Cu \u2014 producing different cell-type selectivity in published research. AHK-Cu&#8217;s strongest research signal is in dermal papilla cells of the hair follicle; <a href=\"https:\/\/medsbase.com\/nl\/ghk-cu\/\">GHK-Cu<\/a>&#8216;s strongest signal is in skin fibroblasts and keratinocytes. The two are often studied in parallel to dissect shared copper-peptide effects from sequence-specific effects.<\/p>\n<h3>What is the typical AHK-Cu research dose?<\/h3>\n<p>Published preclinical protocols typically use 1\u20135\u00a0mg per administration for subcutaneous delivery and 2\u201310\u00a0mg for topical formulation research, given 1\u20133 times daily for 4\u201312 week research cycles. A 20\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 10\u00a0mg\/mL \u2014 0.1\u00a0mL equals 1\u00a0mg, 0.5\u00a0mL equals 5\u00a0mg.<\/p>\n<h3>Is AHK-Cu FDA approved?<\/h3>\n<p>No. AHK-Cu is not approved by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. Copper peptides have been incorporated into some cosmetic products under cosmetic-regulation frameworks, but AHK-Cu specifically has no therapeutic approval. All AHK-Cu sold by research-use-only suppliers is for laboratory investigation and should not be administered to humans.<\/p>\n<h3>How should AHK-Cu be stored?<\/h3>\n<p>Lyophilized vials: refrigerated at 2\u20138\u00a0\u00b0C for short-term working stock, or \u221220\u00a0\u00b0C for long-term storage of unopened vials. Reconstituted solution: refrigerated at 2\u20138\u00a0\u00b0C, use within 30 days. Do not freeze reconstituted solution \u2014 freeze-thaw cycles degrade the peptide and can affect copper coordination. Protect from direct light at all times to preserve copper oxidation state.<\/p>\n<h3>How do I reconstitute AHK-Cu?<\/h3>\n<p>Volg de hierboven beschreven reconstitutieprocedure. Voeg bacteriostatisch water toe langs de zijkant van het flesje (niet rechtstreeks op het gevriesdroogde poeder), draai voorzichtig en laat 2\u20135 minuten staan voor volledige oplossing. Schud <strong>niet<\/strong> shake the vial. A correctly reconstituted solution is clear with the characteristic blue colour of the bound Cu<sup>2+<\/sup> \u2014 the colour itself confirms successful reconstitution and intact copper coordination. For a 20\u00a0mg vial + 2.0\u00a0mL diluent, the working concentration is 10\u00a0mg\/mL.<\/p>\n<h3>Welke sterktes heeft MedsBase op voorraad?<\/h3>\n<p>MedsBase carries AHK-Cu in 20\u00a0mg and 50\u00a0mg lyophilized vials. Each strength is available in 10-vial or 20-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request.<\/p>\n<h3>Why is AHK-Cu blue in colour?<\/h3>\n<p>The characteristic blue-to-violet colour of AHK-Cu (and GHK-Cu) comes from the d-d electronic transitions of bound Cu<sup>2+<\/sup> in the square-planar coordination environment created by the histidine residue and the peptide backbone. The colour is a useful qualitative indicator of successful copper coordination \u2014 a properly reconstituted blue solution confirms intact Cu<sup>2+<\/sup> binding, while a colourless or pale solution would indicate copper loss or degradation. This is unique among small peptides \u2014 most synthetic peptides yield colourless solutions when reconstituted.<\/p>\n<h3>How does AHK-Cu compare to finasteride or minoxidil?<\/h3>\n<p>The three target hair-loss biology through completely different mechanisms. Finasteride blocks 5-alpha-reductase to lower scalp dihydrotestosterone (DHT) levels \u2014 an androgen-axis mechanism. Minoxidil opens ATP-sensitive potassium channels to vasodilate follicular vessels \u2014 a vascular mechanism. AHK-Cu provides direct copper-cofactor delivery and VEGF-mediated follicular vascularization at the dermal papilla cell level \u2014 a mesenchymal-cell mechanism. The three mechanisms are orthogonal, which makes AHK-Cu a useful research tool for studying follicular biology independent of androgen-axis or vasodilation-mediated effects.<\/p>\n<h3>Does AHK-Cu cause side effects in research?<\/h3>\n<p>Published preclinical research has reported a notably clean safety profile at typical research doses, with the main on-target effect being follicular stimulation. Off-target findings can include local injection-site irritation and (with prolonged high-dose topical exposure) modest cutaneous discolouration from copper deposition \u2014 both reversible with discontinuation. Systemic adverse effects from topical applications are rare due to limited transcutaneous absorption.<\/p>\n<h3>What is the half-life of AHK-Cu?<\/h3>\n<p>In preclinical research, AHK-Cu has a relatively short plasma half-life (~1\u20132 hours) following subcutaneous administration. The short half-life is offset by retention of bound copper in target tissues \u2014 even after plasma clearance, the copper delivered to dermal papilla cells continues to support follicular biology through its enzyme-cofactor roles. Topical formulations provide sustained local exposure that is more relevant for hair-axis research than the systemic plasma profile.<\/p>\n<h3>Can AHK-Cu and GHK-Cu be stacked in research?<\/h3>\n<p>Yes. The two copper peptides target different cell types (dermal papilla for AHK-Cu, dermal fibroblasts for GHK-Cu) and address different research domains (hair vs skin), so co-administration is not pharmacologically redundant. Research protocols studying combined skin-and-hair endpoints \u2014 for example, comprehensive dermatological remodelling research \u2014 sometimes use both arms.<\/p>\n<h3>How long does AHK-Cu take to show effects in preclinical research?<\/h3>\n<p>Acute effects on dermal papilla cell VEGF expression are detectable within 24\u201372 hours in cell-culture research. Follicular size and anagen-prolongation effects in rodent hair-cycle models typically become statistically significant after 4\u20138 weeks of regular treatment and continue to accrue through 12\u201316 weeks \u2014 matching the natural hair-cycle timeframe.<\/p>\n<h3>Can I order AHK-Cu for international shipping?<\/h3>\n<p>Yes. MedsBase ships AHK-Cu worldwide from our dedicated peptide shipping network. Peptide-only orders qualify for our standalone peptide shipping service. All orders ship in temperature-controlled packaging with full tracking and are covered by our <a href=\"https:\/\/medsbase.com\/nl\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Hair, Skin, and Tissue-Regeneration Research<\/h2>\n<ul>\n<li><a href=\"\/nl\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Sister copper-binding tripeptide \u2014 canonical skin remodelling and wound-healing research compound<\/li>\n<li><a href=\"\/nl\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tissue-regeneration and recovery research<\/li>\n<li><a href=\"\/nl\/tb-500\/\"><strong>TB-500 (Thymosin Beta-4)<\/strong><\/a> \u2014 Systemic healing fragment \u2014 tissue and vascular recovery research<\/li>\n<li><a href=\"\/nl\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 longevity and circadian research<\/li>\n<li><a href=\"\/nl\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Nootropic heptapeptide \u2014 CNS research compound<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Verder lezen<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore the copper-peptide research landscape<\/strong><\/p>\n<p style=\"margin: 0;\">Bekijk het volledige <a href=\"https:\/\/medsbase.com\/nl\/peptides\/\"><strong>onderzoekspeptiden catalogus<\/strong><\/a>, with related dermatology and tissue-regeneration compounds including <a href=\"https:\/\/medsbase.com\/nl\/ghk-cu\/\">GHK-Cu<\/a> (sister copper peptide for skin research), <a href=\"https:\/\/medsbase.com\/nl\/bpc-157\/\">BPC-157<\/a> (tissue regeneration), and <a href=\"https:\/\/medsbase.com\/nl\/tb-500\/\">TB-500<\/a> (systemic healing).<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Alanyl-Histidyl-Lysine Copper(II) tripeptide<br \/>\n\u2705 Sister molecule to GHK-Cu<br \/>\n\u2705 Hair follicle biology research compound<br \/>\n\u2705 Dermal papilla cell stimulation, anagen prolongation<br \/>\n\u2705 Orthogonal to finasteride\/minoxidil mechanisms<\/p>\n<p><strong>AHK-Cu<\/strong> contains synthetic copper-peptide complex.<\/p>","protected":false},"featured_media":70940,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6290,5441],"class_list":{"0":"post-70789","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-ahk-cu","8":"product_tag-peptide","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product\/70789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/comments?post=70789"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media\/70940"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media?parent=70789"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_brand?post=70789"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_cat?post=70789"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_tag?post=70789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}